Kobusiak-Prokopowicz Małgorzata, Orzeszko Jacek, Mazur Grzegorz, Mysiak Andrzej, Orda Alina, Mazurek Walentyna
Department of Cardiology, Medical Academy, Wrocław, Poland.
Kardiol Pol. 2005 Apr;62(4):301-14; discussion 315-6.
Chemokines are supposed to play an important role in the activation of monocytes and in the development of atherosclerosis. There are also suggestions that chemokine-mediated enhanced coagulability may be related to the pathogenesis of acute coronary syndromes.Aim. To assess the kinetics of 3 chemokines: Monocyte Chemoattractant Protein-1 (MCP-1), Macrophage Inflammatory Protein-1alfa (MIP-1alpha) and Regulated on Activation Normal T cell Expressed and Secreted (RANTES) in patients with ST-elevation myocardial infarction (STEMI).
The study group consisted of 40 patients (pts) with STEMI who were divided into 2 groups -- 16 pts with anterior MI (AMI) and 24 pts with inferior or lateral MI (IMI). According to the type of received therapy, the pts were divided into 2 other groups: group A -- 30 pts treated with thrombolytic agents or primary angioplasty and group B -- 10 pts without recanalisation therapy. The control group consisted of 10 healthy volunteers. Blood samples for MCP-1, MIP-1alpha and RANTES serum levels was taken on admission and 3 h, 24 h, 48 h, 72 h and 7 days afterwards.
The baseline MCP-1 and RANTES levels were significantly higher in pts with STEMI than in controls (1068.9 vs 880.9 pg/ml, p<0.05; 50.8 vs 33.9 pg/ml, p<0.005). In pts with STEMI, peak levels of MCP-1 and MIP-1alpha were significantly higher 3h than 24h from admission (MCP-1 1274.4 vs 1097.4 pg/ml, p<0.02; MIP-1alpha 39.2 vs 22.0 pg/ml, p<0.01). In all STEMI pts there was a positive correlation between MIP-1alpha 3h and left ventricular ejection fraction (LVEF) (r=0.455, p<0.05) and a negative correlation between MIP-1alpha 3h and LV end-diastolic diameter (LVEED) (r=-0.453, p<0.05). A significant positive correlation between TnI level and chemokines in both AMI and IMI patients was detected, being the highest in AMI and IMI groups when MIP-1alpha 24 h and TnI were compared (R=0.852, p<0.003 and R=0.646, p<0.0001). In pts with IMI, a positive correlation between RANTES, MIP-1alpha 3h and LVEF was found (R=0.322, p<0.03 and R=0.399, p<0.008). In group A, all MIP-1alpha values were significantly higher than in group B. Also, peak MIP-1alpha levels significantly differed between groups A and B (44.8 vs 8.3 pg/ml, p<0.006). In pts from group B, a negative correlation between MCP-1 measured an admission and LVEF was found (R=-0.690, p<0.05).
We found a significant elevation of chemokines in the early period of acute MI. The correlations between different parameters suggest, that chemokines may serve as new parameters of immune activation in STEMI and also may play the dominant role in the cardiac inflammatory response and subsequent repair processes.
趋化因子被认为在单核细胞的激活以及动脉粥样硬化的发展过程中发挥重要作用。也有观点认为趋化因子介导的凝血增强可能与急性冠脉综合征的发病机制有关。目的:评估ST段抬高型心肌梗死(STEMI)患者体内三种趋化因子:单核细胞趋化蛋白-1(MCP-1)、巨噬细胞炎性蛋白-1α(MIP-1α)和正常T细胞激活后表达和分泌因子(RANTES)的动力学变化。
研究组由40例STEMI患者组成,这些患者被分为两组——16例前壁心肌梗死(AMI)患者和24例下壁或侧壁心肌梗死(IMI)患者。根据接受的治疗类型,患者又被分为另外两组:A组——30例接受溶栓治疗或直接血管成形术的患者;B组——10例未接受再灌注治疗的患者。对照组由10名健康志愿者组成。入院时以及之后3小时、24小时、48小时、72小时和7天采集血样,检测MCP-1、MIP-1α和RANTES的血清水平。
STEMI患者的基线MCP-1和RANTES水平显著高于对照组(分别为1068.9 vs 880.9 pg/ml,p<0.05;50.8 vs 33.9 pg/ml,p<0.005)。在STEMI患者中,MCP-1和MIP-1α的峰值水平在入院后3小时显著高于24小时(MCP-1:1274.4 vs 1097.4 pg/ml,p<0.02;MIP-1α:39.2 vs 22.0 pg/ml,p<0.01)。在所有STEMI患者中,3小时时的MIP-1α与左心室射血分数(LVEF)呈正相关(r=0.455,p<0.05),与左心室舒张末期内径(LVEED)呈负相关(r=-0.453,p<0.05)。在AMI和IMI患者中均检测到肌钙蛋白I(TnI)水平与趋化因子之间存在显著正相关关系;当比较24小时时的MIP-1α和TnI时,在AMI和IMI组中相关性最高(R=0.852,p<0.003;R=0.646,p<<0.0001)。在IMI患者中,发现RANTES、3小时时的MIP-1α与LVEF之间呈正相关(R=0.322,p<0.03;R=0.399,p<0.008)。在A组中,所有MIP-1α值均显著高于B组。此外,A组和B组的MIP-1α峰值水平存在显著差异(44.8 vs 8.3 pg/ml,p<0.006)。在B组患者中,入院时检测的MCP-1与LVEF呈负相关(R=-0.690,p<0.05)。
我们发现急性心肌梗死早期趋化因子显著升高。不同参数之间的相关性表明,趋化因子可能作为STEMI免疫激活的新参数,并且可能在心脏炎症反应及随后的修复过程中起主导作用。